<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>p53-deficient cancer &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/p53-deficient-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 22 Jan 2026 20:40:08 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>p53-deficient cancer &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting Thymine Glycosylase Kills p53-Deficient Cancer Cells</title>
		<link>https://bioengineer.org/targeting-thymine-glycosylase-kills-p53-deficient-cancer-cells/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 20:39:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[C-271]]></category>
		<category><![CDATA[C-271 inhibitor]]></category>
		<category><![CDATA[dsRNA immune response** **Kısaca açıklama:** 1. **Thymine DNA glycosylase:** Makalenin temel hedef proteini ve araştırmanın ana konusu. 2. **Synthetic lethality:** TDG inhibisyonun]]></category>
		<category><![CDATA[İçeriğe göre en uygun 5 etiket: **Thymine DNA glycosylase]]></category>
		<category><![CDATA[Kanser Tedavisi]]></category>
		<category><![CDATA[p53 eksikliği]]></category>
		<category><![CDATA[p53-deficient cancer]]></category>
		<category><![CDATA[sentetik letalite]]></category>
		<category><![CDATA[Synthetic lethality]]></category>
		<category><![CDATA[TDG inhibitörü]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-thymine-glycosylase-kills-p53-deficient-cancer-cells/</guid>

					<description><![CDATA[In a groundbreaking study, researchers have unveiled the intricate role of thymine DNA glycosylase (TDG) in the realm of cancer biology, particularly in p53-deficient tumors. The protein TDG, known for its multifaceted functions in base-excision repair, DNA demethylation, and transcriptional regulation, has garnered attention for its unexpected involvement in embryonic development and the complex mechanisms [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319449</post-id>	</item>
	</channel>
</rss>
